Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Tumor Of Duodenum	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Allopurinol Acute Biphenotypic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Allopurinol Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Allopurinol Myelodysplastic Syndrome With Excess Blasts-1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Allopurinol B-Cell Chronic Lymphocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Allopurinol T-Cell Non-Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells CBL-Related Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Central Nervous System Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Non-Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells B-Lymphoblastic Leukemia/Lymphoma With IAMP21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Monosomy 7 Myelodysplasia And Leukemia Syndrome 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Neurofibromatosis Type 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Li-Fraumeni Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Thymoglobulin, Rabbit Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Thymoglobulin, Rabbit Adrenoleukodystrophy With Cerebral Involvement	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Thymoglobulin, Rabbit Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Thymoglobulin, Rabbit Alpha-methylacyl-CoA Racmase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Thymoglobulin, Rabbit Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 151 to 175 of 705 assets

PreviousPage 7 of 29Next